Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. The Company's product candidates are based on the Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD). The Company has multiple ongoing programs to evaluate Gemini, including GEM-AKI as a prevention of acute kidney injury (AKI), GEM-CKD as a treatment for chronic kidney disease (CKD), and GEM-PSI as a prevention of post-surgical infection (PSI). The Gemini-AKI program is being developed as a potential therapy for the prevention of AKI due to external stress or insult, such as surgical procedure and chemotherapy toxicity. GEM-PSI is being developed as a potential therapy for the prevention or treatment of healthcare-associated bacterial infections, including post-surgical infection, post-burn infection, urinary tract infection, sepsis, and antibiotic-resistant infection.
Find out what a historical investment in Revelation Biosciences Inc would be worth today using our REVB stock calculator.
Buying REVB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Revelation Biosciences Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in REVB
What is the ticker symbol of Revelation Biosciences Inc?
The ticker symbol for Revelation Biosciences Inc is REVB.
How much is one share of REVB?
One share of REVB is valued at $3.69 as of 20 November 2026.
What is the market capitalisation of Revelation Biosciences Inc REVB?
As of 20 November 2026 Revelation Biosciences Inc has a market cap of $2.63M.
What is the 52-week high for Revelation Biosciences Inc stock?
The Revelation Biosciences Inc 52-week high stock price is $40.60.
What is the 52-week low for Revelation Biosciences Inc stock?
The Revelation Biosciences Inc 52-week low stock price is $3.08.
Can I buy REVB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy REVB shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in REVB on Stake
Buy REVB from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of REVB from only US$10 with fractional shares